Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 1336-1342, December 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enomoto, M.
Right arrow Articles by Miller, E. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Enomoto, M.
Right arrow Articles by Miller, E. C.

Urinary Metabolites of 2-Acetylaminofluorene and Related Compounds in the Rhesus Monkey*

Makoto Enomoto{dagger}, Prabhakar Lotlikar, James A. Miller and Elizabeth C. Miller

( McArdle Memorial Laboratory for Cancer Research and Department of Pathology, Medical School, University of Wisconsin, Madison, Wisconsin)

The urinary metabolites of 2-acetylaminofluorene (AAF) and related compounds were determined by paper chromatography after oral administration to young, adult, female monkeys (Macacus rhesus). AAF, N-hydroxy-AAF, and 2-aminofluorene each gave rise to AAF and conjugates of N-hydroxy-AAF and 7-hydroxy-AAF in the urine. Thus the rhesus monkey has the ability to hydroxylate AAF on the nitrogen and 7-carbon atoms, to reduce N-hydroxy-AAF to AAF, and to N-acetylate 2-aminofluorene. No 1-, 3-, or 5-hydroxy derivatives of AAF were detected in these urines. Only small amounts of 1- and 3-hydroxy-AAF were excreted in the urine when large amounts of these respective compounds were fed. N-Hydroxy-AAF was isolated in crystalline form from the urine after administration of AAF by a procedure which involved the intermediate isolation of the poorly soluble cupric chelate of N-hydroxy-AAF.

4-Aminobiphenyl appeared to be metabolized by the rhesus monkey to yield small amounts of N-hydroxy-4-acetylaminobiphenyl in the urine. Ingestion of either 2-aminonaphthalene or its N-acetyl derivative appeared to give a trace of a urinary metabolite with the properties of the corresponding N-hydroxy-N-acetyl derivative.

* This investigation was supported by Grants C355 and HE-06287 of the National Institutes of Health, United States Public Health Service; a grant from the Jane Coffin Childs Memorial Fund for Medical Research; and by the Alexander and Margaret Stewart Trust Fund. We are grateful to Mrs. JoEllen McDowell of the Wisconsin Primate Center for valuable technical assistance.

{dagger} On leave from the Department of Pathology, University of Tokyo. International Postdoctoral Research Fellow, U.S. Public Health Service, 1961–62.

Received 7/16/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.